IFN-gamma

IFN-gamma Overview

English NameInterferon gammaApproved Drugs4
Drugs in Clinical Trials13Target SynonymImmune interferon,Interferon gamma,IFNG,IFN-Gamma,IFG,IFI,Interferon-gamma
Highest Development StageApproved
English NameInterferon gamma
Target SynonymImmune interferon,Interferon gamma,IFNG,IFN-Gamma,IFG,IFI,Interferon-gamma
Approved Drugs4
Drugs in Clinical Trials13
Highest Development StageApproved

IFN-gamma Product List

  • Product Category

    Protein (5)Antibody (6)Kits (9)

  • Product Status

    Launched (19)In Research (1)

  • Species

    Human (9)Mouse (11)

  • Tag

    Tag Free (3)- (15)His Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (9)- (9)Biotin-labeled (2)

IFN-gamma Background

Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression.

IFN-gamma Synonyms

Interferon-gamma ,Interferon-γ

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
PDS-0101PDS-0101B; PDS-0101C; PDS-0101; PDS-0101A; PDS-101Phase 3 ClinicalPds Biotechnology CorpAnus Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplasms; HIV Infections; Oropharyngeal Neoplasms; Papillomavirus Infections; Uterine Cervical Neoplasms; Vulvar Neoplasms
Details
Tadekinig alfar-hIL-18BP; IL-18BPPhase 3 ClinicalAb2 Bio LtdAutoimmune Lymphoproliferative Syndrome; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome
Details
SFA-002SFA-002; SFA002Phase 3 ClinicalSFA Therapeutics IncArthritis, Rheumatoid; Plaque psoriasis; Psoriasis
Details
IMNN-001GEN-1; EGEN-001; IMNN-001; phIL-12-005/PPCPhase 3 ClinicalExpression GeneticsCarcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Cystadenocarcinoma; Cystadenocarcinoma, Serous; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Details
TAX-2TAX-2; AP-01; AP-02Phase 2 ClinicalCentre National De La Recherche Scientifique (Cnrs), University of ReimsSolid tumours; Thrombosis
Details
OCH-NCNP1OCH-NCNP1Phase 2 ClinicalKeio UniversityCrohn Disease; Multiple Sclerosis
Details
KIO-101PP-001; KIO-101; KIO-104Phase 2 Clinical4sc AgConjunctival Diseases; Dry Eye Syndromes; Eye Diseases; Keratoconjunctivitis; Uveitis; Xerophthalmia
Details
ASN-002 (Ascend Biopharmaceuticals)TG-1042; Ad-IFNγ; SP-002 (Ascend Biopharmaceuticals)Phase 2 ClinicalTransgene SaBasal Cell Nevus Syndrome; Carcinoma, Basal Cell; Lymphoma, B-Cell; Skin Melanoma; Skin Neoplasms; Solid tumours
Details
IndemakitugEI-001Phase 2 ClinicalElixiron Immunotherapeutics IncVitiligo
Details
IFN-gamma-secreting HAdV antigen specific T cells (Case Comprehensive Cancer Center)Phase 1 ClinicalCase Comprehensive Cancer CenterHematopoietic stem cell transplantation (HSCT)
Details
Recombinant human interferon gamma adenovirus injection (Guangzhou Dabo Biological Products)Phase 1 ClinicalGuangzhou Dabo Biological Products Co LtdLiver Neoplasms; Nasopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
TAGX-0003TAGX-0003; CGB-600Phase 1 ClinicalTagCyx BiotechnologiesAlopecia Areata; Autoimmune Diseases; Cystitis, Interstitial; Skin Diseases; Vitiligo
Details
[89Zr]Zr-DFO-emapalumab[89Zr]Zr-DFO-emapalumabPhase 1 ClinicalBarbara Ann Karmanos Cancer InstituteCarcinoma, Non-Small-Cell Lung
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Cadi-05Cadi-05ApprovedNational Institute Of Allergy And Infectious Diseases (Niaid)Immuvac, Leprovac, Mycidac-CIndiaLeprosy; Carcinoma, Non-Small-Cell Lungnull1998-01-01Carcinoma, Non-Small-Cell Lung; Leprosy; Squamous Cell Carcinoma of Head and Neck
Details
PropagermaniumSK-818; SK-818CApprovedSanwa Kagaku Kenkyusho Co LtdSerocionJapanHepatitis BSanwa Kagaku Kenkyusho Co Ltd1994-01-01Hepatitis B
Details
EmapalumabNI-0501ApprovedNovimmune SaGamifantUnited StatesLymphohistiocytosis, HemophagocyticNovimmune Sa2018-11-20Arthritis, Juvenile; Cytopenia; Dermatomyositis; Hematopoietic stem cell transplantation (HSCT); Immune System Diseases; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Polyendocrinopathies, Autoimmune; Rare Diseases; Sepsis; Still's Disease, Adult-Onset
Details
ThalidomideNSC-66847; NSC-527179; K-17; FPF-300; FPF300ApprovedCelgene CorpTalizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, ThaledMainland ChinaLeprosy, Lepromatous; Multiple MyelomaChangzhou Pharmaceutical Factory1982-01-01Acquired Immunodeficiency Syndrome; Adenocarcinoma, Clear Cell; Adenoma, Islet Cell; Amyotrophic Lateral Sclerosis; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Angiodysplasia; Appendiceal Neoplasms; Arachnoiditis; Arteriovenous Malformations; Axial Spondyloarthritis; beta-Thalassemia; Burning Mouth Syndrome; Carcinoid Tumor; Carcinoma, Adenosquamous; Carcinoma, Hepatocellular; Cholangitis, Sclerosing; Colorectal Neoplasms; Cough; Endometrial Neoplasms; Endometriosis; Epilepsy; Erythema Nodosum; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Genetic Diseases, Inborn; Glioma; Graft vs Host Disease; Head and Neck Neoplasms; Hemoglobinopathies; HIV Infections; HIV Wasting Syndrome; Hodgkin Disease; Hormone-Resistant Prostate Neoplasms; Hypertension, Portal; Idiopathic Pulmonary Fibrosis; Kidney Neoplasms; Leiomyosarcoma; Leprosy, Lepromatous; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelomonocytic, Chronic; Liver Neoplasms; Lung Neoplasms
Details

Product Reviews

  • M***r2025-10-31
    0People Like
    Reliable and easy-to-use ELISA kit with high sensitivity and consistent results. Standards and controls performed as expected, and the shorter assay time is a great advantage for our studies.
  • Overview
  • Product List
  • Marketed Drug Information
  • Product Reviews
  • Clinical Drug Information